4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0001209191-22-047651
Options or other derivatives
- Chief Operating Officer acquired 130,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Sloan Leslie Chief Operating Officer | 2022-08-23 | Grant or award · Employee Stock Option (right to buy) | +130,000 | 130,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…